Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Neuropeptides. 2006 Nov 14;41(1):39–44. doi: 10.1016/j.npep.2006.10.002

Figure 2.

Figure 2

Shows RT-PCR results by region, treatment, and time for ERα mRNA (a–c) and ERβ mRNA (d–f). 2 hr oxytocin (OT) treatment significantly increased ERα mRNA expression in the hypothalamus (b) and the hippocampus (c), but not the cortex (a). Additionally treatment with an oxytocin antagonist (OTA) decreased ERα mRNA expression in the hippocampus. There were no treatment effects on ERβ mRNA expression. Different letters indicate a significant difference between treatments (P < 0.05).